Dr. Wu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Massachusetts Eye and Ear Infirmary
Retina Service - 243 Charles Street
Boston, MA 02114Phone+1 617-573-3492Fax+1 617-573-3698
Summary
- Dr. David Wu is a vitreoretinal surgeon and scientist with Mass Eye and Ear’s Retina Service who sees patients and conducts retina research in Boston. He specializes in diseases of the retina, including retinal detachments, diabetic retinopathy, retinal vascular occlusions, epiretinal membranes, macular holes, age-related macular degeneration (AMD), retinal arterial and venous occlusions, and diabetic retinopathy. He has a particular interest in the repair of complex retinal detachments, including those secondary to proliferative vitreoretinopathy and diabetic-related traction.
Dr. Wu earned his MD/PhD from the University of Michigan Medical School and trained at the University of Michigan’s W.K. Kellogg Eye Center for his Ophthalmology Residency and a Medical Retina/Research Fellowship. He then completed his Vitreoretinal Surgery fellowship at the Doheny Eye Institute / University of Southern California and Los Angeles County Hospital (USC+LAC). He subsequently joined Mass Eye and Ear, building a respected clinical and surgical practice and a reputation as an educator and scientist before joining the faculty at the Wilmer Eye Institute/Johns Hopkins School of Medicine. He returns to Boston as the Joan Whitten Miller scholar in retina.
Dr. Wu is one of the few vitreoretinal surgeons with expertise in cutting-edge molecular techniques to advance research from bench to bedside. Clinically, he has been voted one of Boston Magazine’s Top Doctors since 2017. He is passionate about ophthalmology education and has won teaching awards for training students and residents through his career. In the laboratory, he has been funded by the NIH as well as private foundations and is the co-inventor of a gene therapy vector with the potential to treat AMD and retinal degenerations. He has presented nationally and internationally on retina surgery and retinal laboratory science, publishing multiple research and clinical manuscripts as well as book chapters.
Education & Training
- University of Southern California/LAC+USC Medical CenterFellowship, Surgical Retina and Vitreous, 2010 - 2012
- University of Michigan Health SystemResidency, Ophthalmology, 2006 - 2009
- Grand Rapids Medical Education and Research Center/ Michigan State University (St Mary's)Internship, Transitional Year, 2005 - 2006
- University of Michigan Medical SchoolClass of 2005
- University of Michigan School of Public HealthPh.D., Neuroscience (Neuroscience Graduate Program), 1998 - 2003
- University of Michigan, College of Literature, Sciences, and the ArtsB.S., Inteflex Program, With distinction, 1993 - 1997
Certifications & Licensure
- CA State Medical License 2010 - 2026
- MA State Medical License 2012 - 2025
- MI State Medical License 2005 - 2025
- MD State Medical License 2019 - 2021
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Award for Excellence in Resident Training Doheny Eye Institute/Keck School of Medicine, 2011
- Selected to present at the AUPO Resident & Fellow Research Forum 2009
- Walter R. Parker Award for Best Resident Teaching Second Place 2009
- Join now to see all
Publications & Presentations
PubMed
- 15 citationsAssociation of the Affordable Care Act Medicaid Expansion with Dilated Eye Examinations among the United States Population with Diabetes.Evan M. Chen, Grayson W. Armstrong, Jacob T. Cox, David M. Wu, Donald R. Hoover
Ophthalmology. 2020-07-01 - 143 citationsAAV cis-regulatory sequences are correlated with ocular toxicityWenjun Xiong, David M. Wu, Yunlu Xue, Sean K. Wang, Michelle Chung
Proceedings of the National Academy of Sciences of the United States of America. 2019-03-19 - 18 citationsAAV-Txnip prolongs cone survival and vision in mouse models of retinitis pigmentosa.Yunlu Xue, Sean K. Wang, Parimal Rana, Emma R. West, Christin M Hong
Elife. 2021-04-13
Journal Articles
- The electrotonic architecture of the retinal microvasculature: modulation by angiotensin IIZhang T. Wu DM. Xu G. Puro DG., J Physiology, 1/1/2011
- Diabetes-induced inhibition of voltage-dependent calcium channels in the retinal microvasculature: role of spermineMatsushita K. Fukumoto M. Kobayashi T. Kobayashi M. Ishikazi E. Minami M. Katsumura K. Liao SD. Wu DM. Zhang T. Puro DG., IOVS, 1/1/2010
- Long-term follow-up of a family with dominant X-linked retinitis pigmentosaWu, DM. Khanna, H. Atmaca-Sonmez, P. Sieving PA. Branham K. Othman M. Swaroop A. Daiger SP. Heckenlively JR., Eye, 1/1/2010
- Join now to see all
Press Mentions
- Current Practice Preferences and Safety Protocols for Intravitreal Injection of Anti-Vascular Endothelial Growth Factor AgentsMarch 22nd, 2020
- AbstractsFebruary 19th, 2021
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: